Biotechnology firm, Calcivis, is targeting the US after securing £5 million to roll out its dental technology and revolutionise early intervention in tooth decay.
Biotechnology firm, Calcivis, is targeting the US after securing £5 million to roll out its dental technology and revolutionise early intervention in tooth decay.
